FDA
approval
· 2021-04-02
FDA Approved: RAMIPRIL — Supplemental Application (Lupin Pharmaceuticals, Inc.)
Summary
The FDA approved Lupin Pharmaceuticals' supplemental application for ramipril (generic ACE inhibitor), enabling continued marketing with the approved changes.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for RAMIPRIL (RAMIPRIL)